Effect of pentoxifylline on diabetic distal polyneuropathy in type 2 diabetic patients: A randomized trial
Background: Diabetes is one of the most common causes of peripheral neuropathy. There are no known cures for diabetic neuropathy. Pentoxifylline could theoretically be a beneficial treatment for diabetic sensory neuropathy, but there is not enough evidence to prove its effect. The aim of this study...
Main Authors: | Frahad Hosseini, Abolfazl Mohammadbeigi, Mohammad Aghaali, Razieh Borujerdi, Mahmoud Parham |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2019-01-01
|
Series: | Journal of Research in Medical Sciences |
Subjects: | |
Online Access: | http://www.jmsjournal.net/article.asp?issn=1735-1995;year=2019;volume=24;issue=1;spage=89;epage=89;aulast=Hosseini |
Similar Items
-
Effects of Pentoxifylline on Nitric Oxide Levels and Histopathology of Pancreas in Diabetic Mice
by: Farin Malekifard, et al.
Published: (2018-07-01) -
The Effect of Pentoxifylline in Reducing Proteinuria in Patients with Diabetic Nephropathy Treated with ACEI or ARB
by: Iranparvar, et al.
Published: (2017-10-01) -
Differential diagnosis of polyneuropathies in diabetes mellitus
by: V. N. Khramilin
Published: (2021-09-01) -
A comparative double-blind randomized study on the effectiveness of Duloxetine and Gabapentin on painful diabetic peripheral polyneuropathy
by: Majdinasab N, et al.
Published: (2019-06-01) -
Pathogenesis of Distal Symmetrical Polyneuropathy in Diabetes
by: Sasha Smith, et al.
Published: (2022-07-01)